Login to Your Account



Pharma: Other News To Note


Thursday, September 13, 2012
• H. Lundbeck A/S, of Copenhagen, Denmark, said the FDA accepted a resubmission of a new drug application by for aripiprazole depot formulation, which is in development for schizophrenia.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription